Citi, V.; Barresi, E.; Piragine, E.; Spezzini, J.; Testai, L.; Da Settimo, F.; Martelli, A.; Taliani, S.; Calderone, V.
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines. Int. J. Mol. Sci. 2023, 24, 16131.
https://doi.org/10.3390/ijms242216131
AMA Style
Citi V, Barresi E, Piragine E, Spezzini J, Testai L, Da Settimo F, Martelli A, Taliani S, Calderone V.
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines. International Journal of Molecular Sciences. 2023; 24(22):16131.
https://doi.org/10.3390/ijms242216131
Chicago/Turabian Style
Citi, Valentina, Elisabetta Barresi, Eugenia Piragine, Jacopo Spezzini, Lara Testai, Federico Da Settimo, Alma Martelli, Sabrina Taliani, and Vincenzo Calderone.
2023. "Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines" International Journal of Molecular Sciences 24, no. 22: 16131.
https://doi.org/10.3390/ijms242216131
APA Style
Citi, V., Barresi, E., Piragine, E., Spezzini, J., Testai, L., Da Settimo, F., Martelli, A., Taliani, S., & Calderone, V.
(2023). Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines. International Journal of Molecular Sciences, 24(22), 16131.
https://doi.org/10.3390/ijms242216131
